Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy

Overview of attention for article published in Journal of Molecular Medicine, June 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 60 patents

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 63 Mendeley

So far, Altmetric has seen 60 patents that reference this research output.

Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy

About this Attention Score

Mentioned by

Citations

Readers on

Modified U6 promoter system for tissue specific expression

Grant US-11939579-B2

United States of America

Compositions and methods for transient delivery of nucleases

Grant US-11920168-B2

United States of America

RAAV-based compositions and methods

Grant US-11920133-B2

United States of America

Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic…

Grant US-11882815-B2

United States of America

Methods of treating amyotrophic lateral sclerosis (ALS)

Grant US-11859179-B2

United States of America

Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization

Grant US-11851657-B2

United States of America

AAV's and uses thereof

Grant US-11834474-B2

United States of America

Method to enhance the efficiency of systemic AAV gene delivery to the central nervous…

Grant US-11826433-B2

United States of America

Isolation of novel AAV's and uses thereof

Grant US-11826434-B2

United States of America

Compositions and methods for modulating dysferlin expression

Grant US-11827886-B2

United States of America

Recombinant virus products and methods for inhibition of expression of DUX4

Grant US-11802291-B2

United States of America

AAV treatment of Huntington's disease

Grant US-11773392-B2

United States of America

RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

Grant US-11760999-B2

United States of America

SOD1 dual expression vectors and uses thereof

Grant US-11739330-B2

United States of America

AAV capsid designs

Grant US-11578340-B2

United States of America

Compositions and methods for treatment of cardiac diseases

Grant US-11566243-B2

United States of America

Recombinant AAV variants and uses thereof

Grant US-11542525-B2

United States of America

Prostate-targeting adeno-associated virus serotype vectors

Grant US-11426469-B2

United States of America

AAV-based treatment of cholesterol-related disorders

Grant US-11421230-B2

United States of America

Compositions and methods for treatment of cardiac diseases

Grant US-11421232-B2

United States of America

Methods and compositions for treating metabolic imbalance

Grant US-11413356-B2

United States of America

Modified U6 promoter system for tissue specific expression

Grant US-11345913-B2

United States of America

MIR-375- AND MIR-1-REGULATED COXSACKIEVIRUS B3 HAS NO PANCREAS AND HEART TOXICITY BUT…

Application WO-2022100898-A1

World Intellectual Property Organisation (WIPO)

Methods and compositions for treating metabolic imbalance in neurodegenerative disease

Grant US-11253576-B2

United States of America

RAAV-based compositions and methods

Grant US-11254939-B2

United States of America